Saving Seniors Money on Prescriptions Act

3/5/2025, 5:08 AM

Saving Seniors Money on Prescriptions Act

This bill establishes reporting requirements for pharmacy benefit managers (PBMs) under the Medicare prescription drug benefit and Medicare Advantage, particularly relating to the prices of prescription drugs.

Specifically, PBMs must (1) disclose certain information underlying cost performance measurements (e.g., exclusions and terms), and (2) report to prescription drug plan (PDP) sponsors (and to the Centers for Medicare & Medicaid Services upon request) an itemized list of prescription drugs that were dispensed during the previous year and related data about costs, claims, affiliated pharmacies, and other specified information. PDP sponsors may audit PBMs to ensure compliance with this bill's requirements and must annually certify their compliance; PBMs are responsible for any associated civil penalties for violations.

In addition, the Government Accountability Office must study federal and state reporting requirements for health plans and PBMs with respect to prescription drug price transparency and recommend ways to streamline these requirements.

Bill 119 HR 950, also known as the Pharmacy Benefit Manager Reporting Act, aims to make changes to Medicare Part D by adding reporting requirements for pharmacy benefit managers (PBMs) in relation to prescription drug plans and Medicare Advantage prescription drug plans (MA-PD plans).

The bill seeks to amend Title XVIII of the Social Security Act to ensure that PBMs are transparent in their operations and provide detailed reports on their activities within Medicare Part D. This includes requiring PBMs to report information such as drug pricing, rebates, and any potential conflicts of interest that may arise.

By implementing these reporting requirements, the goal is to increase transparency and accountability within the Medicare Part D program, ultimately leading to better oversight and potentially lower drug costs for beneficiaries. This bill is an important step towards ensuring that PBMs are held accountable for their actions and that Medicare beneficiaries receive the best possible care at an affordable price.
Congress
119

Number
HR - 950

Introduced on
2025-02-04

# Amendments
0

Sponsors
+5

Cosponsors
+5

Variations and Revisions

2/4/2025

Status of Legislation

Bill Introduced
Introduced to House
House to Vote
Introduced to Senate
Senate to Vote

Purpose and Summary

Saving Seniors Money on Prescriptions Act

This bill establishes reporting requirements for pharmacy benefit managers (PBMs) under the Medicare prescription drug benefit and Medicare Advantage, particularly relating to the prices of prescription drugs.

Specifically, PBMs must (1) disclose certain information underlying cost performance measurements (e.g., exclusions and terms), and (2) report to prescription drug plan (PDP) sponsors (and to the Centers for Medicare & Medicaid Services upon request) an itemized list of prescription drugs that were dispensed during the previous year and related data about costs, claims, affiliated pharmacies, and other specified information. PDP sponsors may audit PBMs to ensure compliance with this bill's requirements and must annually certify their compliance; PBMs are responsible for any associated civil penalties for violations.

In addition, the Government Accountability Office must study federal and state reporting requirements for health plans and PBMs with respect to prescription drug price transparency and recommend ways to streamline these requirements.

Bill 119 HR 950, also known as the Pharmacy Benefit Manager Reporting Act, aims to make changes to Medicare Part D by adding reporting requirements for pharmacy benefit managers (PBMs) in relation to prescription drug plans and Medicare Advantage prescription drug plans (MA-PD plans).

The bill seeks to amend Title XVIII of the Social Security Act to ensure that PBMs are transparent in their operations and provide detailed reports on their activities within Medicare Part D. This includes requiring PBMs to report information such as drug pricing, rebates, and any potential conflicts of interest that may arise.

By implementing these reporting requirements, the goal is to increase transparency and accountability within the Medicare Part D program, ultimately leading to better oversight and potentially lower drug costs for beneficiaries. This bill is an important step towards ensuring that PBMs are held accountable for their actions and that Medicare beneficiaries receive the best possible care at an affordable price.
Alternative Names
Official Title as IntroducedTo amend title XVIII of the Social Security Act to establish pharmacy benefit manager reporting requirements with respect to prescription drug plans and MA-PD plans under Medicare part D.

Comments

Recent Activity

Latest Summary3/10/2025

Saving Seniors Money on Prescriptions Act

This bill establishes reporting requirements for pharmacy benefit managers (PBMs) under the Medicare prescription drug benefit and Medicare Advantage, particularly relating to the pr...


Latest Action2/4/2025
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the ...